跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,737 条关于
“CSS”
全部
3,737
临床试验
2,700
药物
630
机构
54
资讯
353
去年
Atossa Therapeutics' (Z)-Endoxifen Shows Promise in Phase 2 Breast Cancer Trial
去年
Gates Foundation Funds Likarda's Novel Antibody-Secreting Cell Therapy for Infectious Diseases
去年
Tirzepatide Reduces Heart Failure Risk in HFpEF Patients with Obesity: SUMMIT Trial
去年
Tirzepatide Shows Promise in Phase III Trial for Heart Failure with Preserved Ejection Fraction
去年
Bladder Preservation Therapy Gains Ground as Viable Alternative to Cystectomy for Muscle-Invasive Bladder Cancer
去年
Tirzepatide Reduces Heart Failure and CVD Risk in Obese Patients with HFpEF
去年
Tenaya Therapeutics' TN-201 Receives Clearance for Higher Dose Cohort in Hypertrophic Cardiomyopathy Trial
去年
Cascada Silver Amends Angie Copper Molybdenum Project Option Agreement
去年
Early Detection Through Symptom-Based Testing Shows Promise in Ovarian Cancer Diagnosis
2个月前
CurifyLabs Secures €12 Million Series A to Expand 3D-Printed Personalised Medicine Platform Across the U.S.
第 1 页,共 36 页
上一页
下一页